FSD Pharma (NASDAQ:HUGE) Trading Up 4.8%

FSD Pharma Inc. (NASDAQ:HUGE) was up 4.8% during trading on Monday . The company traded as high as $0.53 and last traded at $0.49. Approximately 675,003 shares were traded during mid-day trading, an increase of 398% from the average daily volume of 135,425 shares. The stock had previously closed at $0.47.

FSD Pharma Trading Down 1.1 %

The business has a 50-day simple moving average of $0.72 and a 200 day simple moving average of $0.91. The stock has a market cap of $18.07 million, a P/E ratio of -0.98 and a beta of 0.59.

FSD Pharma (NASDAQ:HUGE) last released its quarterly earnings results on Thursday, March 28th. The company reported ($0.04) EPS for the quarter.

Institutional Investors Weigh In On FSD Pharma

An institutional investor recently bought a new position in FSD Pharma stock. Scotia Capital Inc. purchased a new position in shares of FSD Pharma Inc. (NASDAQ:HUGE) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 61,273 shares of the company’s stock, valued at approximately $55,000. Scotia Capital Inc. owned 0.16% of FSD Pharma as of its most recent filing with the SEC. Hedge funds and other institutional investors own 1.24% of the company’s stock.

FSD Pharma Company Profile

FSD Pharma Inc, a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders.